3-methyl-3,4-dihydro-2H-1,4-benzoxazine,
32329-20-7,
3-Methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine,
3,4-dihydro-3-methyl-2H-1,4-benzoxazine,
3-METHYL-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE,
AC1MC8S4,
DSSTox_CID_24915,
DSSTox_RID_80583,
DSSTox_GSID_44915,
SCHEMBL1146635,
CHEMBL3183910,
DTXSID8044915,
CTK4G8533,
BSDVKBWLRCKPFB-UHFFFAOYSA-N,
BCP14442,
KS-00001A0H,
Tox21_301241,
MFCD01935996,
SBB086646,
AKOS005070238,
3J-356S,
AB10564,
MCULE-9772409492,
RP09981,
2,3-dihydro-3-methyl-1,4-benzoxazine,
NCGC00256302-01,
AM803695,
3-methyl-2H,3H,4H-benzo[e]1,4-oxazine,
CAS-32329-20-7,
TR-013615,
CS-0037800,
FT-0680283,
2H-1,4-Benzoxazine,3,4-dihydro-3-methyl-,
EN300-93875,
Z-2439,
(rs)-3-methyl-3,4-dihydro-2h-[1,4]benzoxazine,
(RS)-3-Methyl-3,4-dihydro-2H-benzo[1,4]oxazine,
J-512847,
I14-18038,
F1905-6501,
Z1269750463,
UNII-LG21YE3V7L,
C9-H11-N-O,
ZINC03883772,
CID2763760,
2H-1,4-Benzoxazine, 3,4-dihydro-3-methyl-,